HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer

NCT01387932 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
235
Enrollment
INDUSTRY
Sponsor class

Stopped The clinical study was terminated due to the inability to meet target enrollment.

Conditions

Interventions

Sponsor

Merit Medical Systems, Inc.